About this episode

This episode discusses novel therapies for Non-Hodgkin Lymphoma with expert insights from leading oncologists.

Featuring perspectives from Dr Christopher Flowers, Dr Matthew Lunning, Dr Sonali M Smith and Dr Brad S Kahl, moderated by Dr Kahl, including the following topics: Rational Incorporation of CD79b-Targeted Antibody-Drug Conjugates into the Management of Newly Diagnosed and Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Flowers (00:00) Clinical Utility of CD19-Directed Monoclonal Antibodies in the Treatment of DLBCL and Follicular Lymphoma (FL) — Dr Smith (31:41) Optimal Use of CD19-Directed Antibody-Drug Conjugates for R/R DLBCL and FL — Dr Lunning (01:03:23) Current and Future Role of Bruton Tyrosine Kinase Inhibition in Therapy for Non-Hodgkin Lymphoma — Dr Kahl (01:26:48) CME information an d select publications

People in this episode

Host: Dr Kahl

Guests: Dr Christopher Flowers, Dr Matthew Lunning, Dr Sonali M Smith, Dr Brad S Kahl

Topics covered

• Non-Hodgkin Lymphoma
• Antibody-Drug Conjugates
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma
• Bruton Tyrosine Kinase Inhibition

Keywords

• Non-Hodgkin Lymphoma
• CD79b
• CD19
• Antibody-Drug Conjugates
• Bruton Tyrosine Kinase
• Diffuse Large B-Cell Lymphoma
• Follicular Lymphoma

Mentioned in this episode

Organizations: ASCO, CD79b-Targeted Antibody-Drug Conjugates, CD19-Directed Monoclonal Antibodies, Bruton Tyrosine Kinase

More episodes of Oncology Today with Dr Neil Love

• Endometrial Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 20, 2026 · 1h 30m
• HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy · July 17, 2026 · 46 min
• For Oncology Nurses: Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Proceedings from the 2026 Annual ONS Congress · July 16, 2026 · 1h 58m
• Ovarian Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting · July 15, 2026 · 2h 1m
• HER2-Altered Non-Small Cell Lung Cancer — Rapid Case Review · July 14, 2026 · 28 min
• Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances · July 13, 2026 · 58 min

Explore listener stats, chart rankings, contacts and more on the Oncology Today with Dr Neil Love podcast page.